Aguado de la Rosa C, Cruz Castellanos P, Lazaro-Quintela M, Domine M, et al. Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study). Lung Cancer 2022;173:83-93.
PMID: 36162227